Parenteral Nutrition Support for Patients With Pancreatic Cancer. A Phase II Study.
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Cancer Cachexia
- Sponsor
- CONKO-Studiengruppe
- Enrollment
- 32
- Locations
- 1
- Primary Endpoint
- nutritional status presented by phase angle
- Status
- Completed
- Last Updated
- 16 years ago
Overview
Brief Summary
The purpose of this study is to determine whether the additional nutrition support is improving the nutritional status of patients suffering cancer caxechia or not.
Detailed Description
To examine the impact of additional parenteral nutrition (APN) we prospective evaluated 32 pts suffering APC and progressive cachexia. This assay is based on a bioelectrical impedance analysis (BIA) as a proven tool for nutritional investigation in patients with chronic disease. Phase angle, determined by BIA, has been found to be a prognostic indicator in several chronic and malignant conditions, such as HIV, liver cirrhosis, chronic obstructive pulmonary disease lung cancer and pancreatic cancer.
Investigators
Eligibility Criteria
Inclusion Criteria
- •histological proved pancreatic cancer
- •progressive cancer cachexia
- •refractive to enteral supplementation
- •informed consent
Exclusion Criteria
- •prefinal status
- •septic disease
Outcomes
Primary Outcomes
nutritional status presented by phase angle
Time Frame: 12 weeks
Secondary Outcomes
- quantity of port infections, quantity of oedema, quantity of diarrhea(12 weeks)